More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year.
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue.
Patient flow automation startup Qventus closed a $105 million Series D financing round. The company's technology is used by more than 115 hospitals and health systems, including Northwestern Medicine, Banner Health and Allina Health.
Solera Health's $40 million Series E round was co-led by Health Care Service Corporation and included participation from Adams Street, Cobalt Ventures, and Horizon Mutual Holdings, Inc.
Solution developers have a key role to play in mapping the full patient experience and providing patients with the tools and knowledge needed to overcome common hurdles and maintain high rates of compliance. Doing so will benefit both patients and innovators.
Technology often plays a critical role in strategies to combat rising costs while maintaining quality care. Here are four trends expected to accelerate in 2025.
In this episode, we're joined by Kathryn Schubert, president and CEO of the Society for Women's Health Research. Schubert discusses the trends in women's health that defined 2024 and what we can expect in the coming year.
No comments